By Cecilia Butini 
 

Valneva SE said Wednesday that it has reached a settlement with the U.K. government related to the termination of a contract for the supply of its Covid-19 vaccine.

The French pharmaceutical company had received a termination notice from the U.K. government in September 2021. It said that the settlement resolves obligations between the two parties in the wake of the contract's end.

Besides the U.K., Valneva was also planning to supply vaccine doses throughout the European Union, and had received acceptance of its marketing authorization application to the EU in May. The company recently said, however, that the number of requested shots to be sent to European Union member states might be too low to keep a vaccine development program running.

 

Write to Cecilia Butini at cecilia.butini@wsj.com

 

(END) Dow Jones Newswires

June 15, 2022 12:26 ET (16:26 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Valneva (EU:VLA)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Valneva
Valneva (EU:VLA)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Valneva